Explore Lonza Biologics' end-to-end Drug Product capabilities along the full life cycle, seamlessly integrated with the drug substance network across biologic modalities. This presentation will highlight recent expansions at the Stein site in Switzerland, including:
- The large-scale commercial manufacturing expansion, dedicated to biologics filling in vials -as liquid or lyophilizates-, as well as in prefilled syringes (PFS) and cartridges.
- The new highly potent ADC manufacturing capabilities, supported by comprehensive development services.